UPC
Universe Pharmaceuticals Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$4.03
−6.93%Margins
Gross margin
33.4%
EBITDA margin
1.4%
EBIT margin
-28.9%
Net margin
-2.3%
FCF margin
-46.7%
-1.5%
Return on equity
-1.2%
Return on assets
-16.4%
Return on invested capital
0.53x
Asset turnover
-$16.4M
Cash from operations
$5.78
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026